Most clinicians hit their target time savings within about 10 uses. At the agency level, the bulk of efficiency gains are visible within 90 days. Agencies consistently report incremental improvements well beyond that as the platform is refined to their workflows and clinicians build fluency.

No. Apricot functions differently from many ambient scribes on the market. Ambient scribe solutions, whether stand-alone or embedded in your EMR, can struggle with noisy environments, miss information that isn’t spoken aloud, or fail entirely when patients don't consent to recording in the home. They can also result in clinicians narrating the visit for the ambient scribe instead of conversing naturally with the patient. Apricot is a comprehensive AI documentation solution: pre-visit patient intelligence, clinician-controlled in-home data capture (including strategic audio capture, photos, vitals, and text-based notes), post-visit interview, and in-app output review. Multi-modal data capture during and after the visit allows for more natural patient interactions and a more complete OASIS packet.

Yes. Apricot is designed for enterprise demands— multi-location support, configurable clinical pathways, and compliance infrastructure at scale—but accessible for agencies at every stage of growth.

Apricot agencies see an 85% reduction in chart time, a 40% increase in QA productivity, and the capacity to take on 2x more SOCs per clinician without adding headcount. The hours clinicians and QA teams get back translate directly into agency capacity: more patients seen, more referrals accepted, same staff. The exact return varies by agency size and workflow, but the math tends to move quickly.